These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22076593)

  • 41. A 'Fine' chemical industry for life science products: green solutions to chemical challenges.
    Bruggink A; Straathof AJ; van der Wielen LA
    Adv Biochem Eng Biotechnol; 2003; 80():69-113. PubMed ID: 12747542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A method to characterize the greenness of solvents used in pharmaceutical manufacture.
    Slater CS; Savelski M
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2007 Sep; 42(11):1595-605. PubMed ID: 17849301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Green approach using monolithic column for simultaneous determination of coformulated drugs.
    Yehia AM; Mohamed HM
    J Sep Sci; 2016 Jun; 39(11):2114-22. PubMed ID: 27062581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Roadmap for implementation of quality by design (QbD) for biotechnology products.
    Rathore AS
    Trends Biotechnol; 2009 Sep; 27(9):546-53. PubMed ID: 19647883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of the cellular targets of bioactive small organic molecules using affinity reagents.
    Leslie BJ; Hergenrother PJ
    Chem Soc Rev; 2008 Jul; 37(7):1347-60. PubMed ID: 18568161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analytical methods for residual solvents determination in pharmaceutical products.
    Grodowska K; Parczewski A
    Acta Pol Pharm; 2010; 67(1):13-26. PubMed ID: 20210075
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alternative solvent-free methodologies in the synthesis of pharmaceutical drugs.
    Shearouse WC; Waddell DC; Mack J
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):772-83. PubMed ID: 19894189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aqueous microwave chemistry: a clean and green synthetic tool for rapid drug discovery.
    Polshettiwar V; Varma RS
    Chem Soc Rev; 2008 Aug; 37(8):1546-57. PubMed ID: 18648680
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of third-party review to reduce health and environmental hazards from surfactants and cleaning products in the janitorial industry.
    Okumura K
    J Environ Health; 2009 May; 71(9):20-3. PubMed ID: 19452830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Separation processes for organic molecules using SCF Technologies.
    Daintree LS; Kordikowski A; York P
    Adv Drug Deliv Rev; 2008 Feb; 60(3):351-72. PubMed ID: 18006179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A recyclable catalytic system based on a temperature-responsive catalyst.
    Hamamoto H; Suzuki Y; Yamada YM; Tabata H; Takahashi H; Ikegami S
    Angew Chem Int Ed Engl; 2005 Jul; 44(29):4536-8. PubMed ID: 15968694
    [No Abstract]   [Full Text] [Related]  

  • 52. On the development of new biocatalytic processes for practical pharmaceutical synthesis.
    Huisman GW; Collier SJ
    Curr Opin Chem Biol; 2013 Apr; 17(2):284-92. PubMed ID: 23462589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Organic synthesis in micro reactors.
    Feng X; Haswell SJ; Watts P
    Curr Top Med Chem; 2004; 4(7):707-27. PubMed ID: 15032684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Green Chemistry Metrics with Special Reference to Green Analytical Chemistry.
    Tobiszewski M; Marć M; Gałuszka A; Namieśnik J
    Molecules; 2015 Jun; 20(6):10928-46. PubMed ID: 26076112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Organic synthesis remains relevant in drug discovery.
    Mehrotra MM
    Nature; 2007 Oct; 449(7162):535. PubMed ID: 17914370
    [No Abstract]   [Full Text] [Related]  

  • 56. Refinement and validation of an exposure model for the pharmaceutical industry.
    McDonnell PE; Cherrie JW; Sleeuwenhoek A; Gilles A; Coggins MA
    J Environ Monit; 2011 Mar; 13(3):641-8. PubMed ID: 21264393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The importance of life cycle concepts for the development of safe nanoproducts.
    Som C; Berges M; Chaudhry Q; Dusinska M; Fernandes TF; Olsen SI; Nowack B
    Toxicology; 2010 Mar; 269(2-3):160-9. PubMed ID: 20025922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Introduction to enzymes in synthesis.
    Hudlicky T
    Chem Rev; 2011 Jul; 111(7):3995-7. PubMed ID: 21671674
    [No Abstract]   [Full Text] [Related]  

  • 59. Toxic pyrolysis products of solvents, paints, and polymer films.
    Peterson JE
    Occup Med; 1993; 8(3):533-47. PubMed ID: 8272978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry.
    Rubin AE; Tummala S; Both DA; Wang C; Delaney EJ
    Chem Rev; 2006 Jul; 106(7):2794-810. PubMed ID: 16836299
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.